- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Oncolytic virotherapy and the current approaches in veterinary medicine ; volume:2 ; number:2 ; year:2022 ; pages:17-27
German journal of veterinary research ; 2, Heft 2 (2022), 17-27
- Klassifikation
-
Landwirtschaft, Veterinärmedizin
- Urheber
-
Bilgiç, Bengü
- DOI
-
10.51585/gjvr.2022.2.0032
- URN
-
urn:nbn:de:101:1-2022120419360039268795
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bilgiç, Bengü
Ähnliche Objekte (12)
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies